AML1-MTG8 leukemic protein induces the expression of granulocyte colony- stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon

Blood

Volumn 96, Issue 1, 2000, Pages 288-296

  Shimizu, Kimiko ^a   Kitabayashi, Issay ^a   Kamada, Nanao ^a   Abe, Tatsuo ^a   Maseki, Nobuo ^a   Suzukawa, Kazumi ^a   Ohki, Misao ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FUSION GENE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0034234513     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.288     Document Type: Article

References (57)

1. Rabbitts TH. Chromosomal translocations in human cancer. Cell. 1991;67:641
2. Look AT. Oncogenic transcription factors in human acute leukemia. Science. 1997;278:1059.
3. Miyoshi H, Shimizu K, Kozu T, et al. t(8;21) break-points on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene. AML1. Proc Natl Acad Sci U S A. 1991;88:10431.
4. Rowley JD. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res. 1984;44:3159.
5. Yamasaki H, Era T, Asou N, et al. High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia. Leukemia. 1995;9:1147.
6. Osato M, Asou N, Abdalla E, et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 1999;93:1817.
7. Downing JR. The AML1-ETO chimeric transcription factor in acute myeloid leukaemia: biology and clinical significance. Br J Haematol. 1999; 106:296.
8. Okuda T, Van Deusen J, Hiebert SW, et al. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 1996;84:321.
9. Wang Q, Stacy T, Binder M, et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A. 1996;93:3444.
10. Okada H, Watanabe T, Niki M, et al. AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene. 1998;17:2287.
11. Kitabayashi I, Yokoyama A, Shimizu K, Ohki M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J. 1998;17:2994.
12. Wang J, Hoshino T, Redner RL, et al. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human M-CoR/mSin3/HDAC1 complex Proc Natl Acad Sci U S A. 1998;95:10860.
13. Kitabayashi I, Ida K, Morohoshi F, et al. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol Cell Biol. 1998;18:846.
14. Klampfer L, Zhang L, Zelenetz AO, et al. The AML1/ETO fusion protein activates transcription of BCL-2, Proc Natl Acad Sci U S A. 1996;93:14059.
15. Ahn MY, Huang G, Bae SC, et al. Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO. Proc Natl Acad Sei U S A. 1998;95:1812.
16. Westendorf JJ, Yamamoto CM, Lenny N, et al. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol. 1998;18:322.
17. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haematopoietic cells. Nature. 1989;339:27.
18. Nicola NA. Hemopoietic cell growth factors and their receptors. Annu Rev Biochem. 1989;58:45.
19. Demetri GD, Griffin JD. Granulocyte-colony stimulating factor and its receptor. Blood. 1991; 78:2791.
20. Fukunaga R, Ishizaka-Ikeda E, Nagata S. Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J Biol Chem. 1990;265:14008.
21. Fukunaga R, Ishizaka-Ikeda E, Pan C-X, et al. Functional domains of the granulocyte colony-stimulating factor receptor EMBO J. 1991;10: 2855.
22. Dong F, Van Buitenen C, Pouwels K, et al. Distinct cytoplasmic regions of the human granulocyle colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol. 1993;13:7774.
23. Dong F, Liu X, De Koning JP, et al. Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. Immunology. 1998;161:6503.
24. Nicholson SE, Novak U, Ziegler SF, Layton JE. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood. 1995;86:3698.
25. Dong F, Brynes RK, Tidow N, et al. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995;333:487.
26. Dong F, Van Paassen M, Van Buitenen C, et al. A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G-CSF-R isoform. Blood. 1995;85: 902.
27. Dong F, Hoefsloot LH, Schelen AM, et al. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci U S A. 1994;91:4480.
28. Kaushansky K. Growth factors and hematopoietic cell fate: a new feature, controversies in hematology. Blood. 1998;92:345.
29. Jacob J, Haug JS, Rapis S, Link DC. Specific signals generated by the cytoplasmic domain of the granulocyte colony-stimulating factor (G-CSF) receptor are not required for G-CSF dependent granulocytic differentiation. Blood. 1997;92:353.
30. Kinashi T, Kwang HL, Ogawa M, et al. Premature expression of the macrophage-colony stimulating factor receptor on a multipotential stem cell line does not alter differentiation lineages controlled by stromal cells used for coculture. J Exp Med. 1991;173:1267.
31. Migriaccio G, Migliaccio AR, Kreider BL, et al. Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol. 1989; 109:833.
32. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper free retroviruses by transient transfection. Proc Natl Acad Sci U S A. 1993;90:8392
33. Miller AD, Miller DG, Garcia JV Lynch CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymol, 1993;217:581.
34. Miyoshi H, Ohira M, Shimizu K, et al. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res. 1995;23:2762.
35. Miyoshi H, Kozu T, Shimizu K, et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 1993;12:2715.
36. Fukunaga R, Ishizaka-Ikeda E, Seto Y, Nagata S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell. 1990; 61:341.
37. Yamanaka RG, Kim D, Radomska HS, et al. CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci U S A. 1997;94:6462.
38. Shimizu K, Ichikawa H, Tojo A, et al. An ets-related gene, ERG, is rearranged in human myeloid leukemia with 1(16;21) chromosomal translocation. Proc Natl Acad Sci U S A. 1993;90:10280.
39. Seto Y, Fukunaga R, Nagata S. Chromosomal gene organization of the human granulocyte colony-stimulating factor receptor. J Immunol. 1992;148:259.
40. Suzuki M, Oda E, Nakajima T, et al. Induction of Sp1 in differentiating human embryonal carcinoma cells triggers transcription of the fibronectin gene. Mol Cell Biol. 1998;18:3010.
41. Zhang D-E, Zhang P, Wang ND, et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A. 1997;94:569.
42. Yamanaka RG, Barlow C, Lekstrom-Himes J, et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A. 1997;94:13187.
43. Chumakov AM, Grillier I, Chumakowa E, et al. Cloning of the novel human myeloid-cell-specific C/EBP∈ transcription factor. Mol Cell Biol. 1997; 17:1375.
44. Radomska HS, Huettner CS, Zhang P, et al. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol. 1998;18:4301.
45. Hohaus S, Petrovick MS, Voso MT, et al. PU. 1 (Spi 1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol Cell Biol. 1995; 15:5830.
46. Smith LT, Hohaus S, Gonzalez DA, et al. PU. 1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood. 1996;88:1234.
47. Williamson EA, Xu HN, Gombart AF, et al. Identification of transcriptional activation and repression domains in human CCAAT/enhancer-binding protein epsilon. J Biol Chem. 1998;273:14796.
48. Morosetti R, Park DJ, Chumakowa AM, et al. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic differentiation. Blood. 1997;90:2591.
49. Motoji T, Watanabe M, Uzumaki H, et al. Granulocyte colony-stimulating factor (G-CSF) receptors on acute myeloblastic leukemia cells and their relationship with the proliferative response to G-CSF in clonogenic assay. Br J Haematol. 1991; 77:54.
50. Tsuchiya H, el-Sonbaty SS, Nagano K, et al. Acute myeloblastic leukemia (ANLL-M2) with t(8; 21) (q22:q22) variant expressing lymphoid but not myeloid surface antigens with a high number of G-CSF receptors. Leuk Res. 1993;17:375
51. Verbeek W, Gombart AF, Chumakov AM, et al. C/EBP∈ directly interacts with the DNA binding Domain of c-myb and cooperatively activates transcription of myeloid promoters. Blood. 1999; 93:3327.
52. Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998; 12:2048.
53. Berger R, Bernheim A, Daniel M-T, et al. Cytologic characterization and significance of normal karyotypes in t(8;21) acute myeloblastic leukemia. Blood. 1982;59:171.
54. Yang FC, Watanabe S, Tsuji K, et al. Human granulocyte colony-stimulating factor (G-CSF) stimulates the in vitro and in vivo development but not commitment of primitive multipotential progenitors from transgenic mice expressing the human G-CSF receptor. Blood. 1998;92:4632.
55. Corral J, Lavenir L, Imply H, et al. An MII-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell. 1996; 85:853.
56. Dobson CL, Warren AJ, Pannell R, et al. The MII-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J. 1999;18:3564.
57. Shimada H, Ichikawa H, Nakamura S, et al. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TISIIb(ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. Blood. In press.